If I understand correctly there was about $500Mn cash on books so the transaction value is actually $3.6Bb. That’s still AUD 5.45Bn. Note also that Razebio was at the point building their own in-house manufacturing plant, so that’s another plus for the acquirer.
One thing less discussed is our sarcophage technology which protects the radiation from the drug molecule from being leaked to the body plus enables double connectors to the cancer cell. I am guessing this technology not only is unique and useful as a platform technology for any Clarity developed drugs but potentially can be used to deliver other cancer targets? What do some scientists around here think of the value of this technology in the scheme of things and how unique and valuable can it be to the acquirers?
- Forums
- ASX - By Stock
- CU6
- Ann: Complete response with Cu-67 SAR-bisPSMA
Ann: Complete response with Cu-67 SAR-bisPSMA, page-65
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
Add CU6 (ASX) to my watchlist
|
|||||
Last
$7.49 |
Change
0.120(1.63%) |
Mkt cap ! $2.365B |
Open | High | Low | Value | Volume |
$7.55 | $7.68 | $7.35 | $10.13M | 1.345M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6 | $7.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.49 | 4963 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6 | 7.470 |
1 | 300 | 7.450 |
4 | 5536 | 7.440 |
3 | 7040 | 7.430 |
1 | 4862 | 7.420 |
Price($) | Vol. | No. |
---|---|---|
7.490 | 4963 | 1 |
7.500 | 350 | 1 |
7.520 | 3450 | 2 |
7.530 | 4862 | 1 |
7.540 | 3003 | 2 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |